Clinical Trial Update: Neoadjuvant Nivolumab in Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of neoadjuvant nivolumab for glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED